ANI Pharmaceuticals Mergers and Acquisitions Summary

Life ScienceCompany

ANI Pharmaceuticals has acquired 14 companies, including 8 in the last 5 years. A total of 1 acquisition came from private equity firms.

ANI Pharmaceuticals’ largest acquisition to date was in 2021, when it acquired Novitium Pharma for $164M. ANI Pharmaceuticals has acquired in 5 different US states, and 4 countries. The Company’s most targeted sectors include life science (86%) and medical products (15%).

Join Mergr and gain access to ANI Pharmaceuticals’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity14
    • M&A Buy Activity14
  • Total Sectors Invested 2
  • Total Countries Invested 4
  • M&A Buy/Sell Connections 11
  • M&A Advisors 6

ANI Pharmaceuticals

ANI Pharmaceuticals, Inc.

210 Main Street West,
Baudette, Minnesota 56623
United States,
(218) 634-3500
www.anipharmaceuticals.com

ANI Pharmaceuticals is a developer, manufacturer, and marketer of top-quality prescription pharmaceuticals. In two facilities with combined manufacturing, packaging, and laboratory capacity exceeding 170,000 sq. ft., ANI develops and manufactures liquid, powder, and oral solid dose products, including those requiring containment. ANI also performs contract manufacturing for some of the largest and most respected pharmaceutical companies in the world. ANI has several ANDAs pending FDA approval and in various stages of development. ANI Pharmaceuticals was formed in 2001 and is based in Baudette, Minnesota.


M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (1.4/yr) # 7 1 3 1 1 1 14
vol $100M $14M $53M $164M $330M
Sell (0.0/yr) # - - - - - - 0
  14

Most Recent M&A

Company Date Value Type
Novitium Pharma 2021-03-09 164M USD Add-on Acquisition
East Windsor, New Jersey · www.novitiumpharma.com
Amerigen Pharmaceuticals - Commercial and Pipeline Generic Products 2020-01-09 53M USD Divestiture
Suzhou, China
Coeptis Pharmaceuticals, Inc. - Seven Development Stage Drug Products 2019-06-18 14M USD Divestiture
Wexford, Pennsylvania
WellSpring Pharma Services 2018-08-09 - Add-on Acquisition
Oakville, Ontario · www.wellspringcmo.com
Amneal Pharmaceuticals LLC - Generic Products and Assets 2018-04-27 - Divestiture
Bridgewater, New Jersey
Impax Laboratories, Inc. - Generic Products and Assets 2018-04-27 - Divestiture
Hayward, California
Holmdel Pharmaceuticals LP - InnoPran XL 2017-02-24 - Divestiture
Cranford, New Jersey
Cranford Pharmaceuticals - Inderal LA Assets 2016-03-11 - Divestiture
, United States
Merck - Two NDAs 2015-09-21 75M USD Divestiture
, United States
Teva Pharmaceutical Industries Ltd. - Flecainide Tablets USP 2015-03-05 - Divestiture
, Israel
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 12 (86%) 277M (84%) - -
Medical Products 2 (14%) 53M (16%) - -
Total 14 $330M - -

By Geo

State/Country Buy Value Sell Value
United States 11 277M - -
  New Jersey 3 164M - -
  Minnesota 2 - - -
  Pennsylvania 1 14M - -
  California 1 - - -
Canada 1 - - -
  Ontario 1 - - -
China 1 53M - -
Israel 1 - - -
Domestic 11 (79%) 277M (84%) - -
Cross-border 3 (21%) 53M (16%) - -
Total 14 $330M - -

Top M&A Advisors

Financial Deals
Truist Securities
1
Houlihan Lokey
1
Bourne Partners Investment Banking
1
Legal Deals
Hughes Hubbard & Reed LLP
1
Oppenheimer Wolff & Donnelly LLP
1

Deal Values

buy # Total
$100M to $1B 1 $164M
< $100M 5 $166M
TOTAL $330M
Largest Novitium Pharma
$164M (2021-03-09)

M&A Connections

Deals
Acquired from
Investor(s)
7%
1 (7%)
Strategic(s)
79%
11 (79%)

 Subscribe to unlock this and 171,468
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.2K Private Equity Firms
  • 161K M&A Transactions
  • 167K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.4K M&A Advisors
    (Investment Banks and Law Firms)
  • 59K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.